PR91310

HYDERABAD, India, Aug. 26, 2021 /PRNewswire=KYODO JBN/ --

    Sai Life Sciences, a leading global Contract Research, Development &

Manufacturing Organization [

https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

(CRO/ CDMO), today announced that it has become a signatory of the United

Nations Global Compact (UNGC), the world's largest sustainability initiative.

As a signatory, Sai Life Sciences has committed itself to adopting the Ten

Principles of the UNGC on human rights, labour, environment and

anti-corruption, reinforcing the company's commitment [

https://www.sailife.com/commitment/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

to corporate responsibility and sustainability.

    Making the announcement, Krishna Kanumuri, CEO & Managing Director said,

"As we pursue our vision and business growth, we consciously integrate our

social, environmental and governance responsibilities. We have committed

ourselves to implement Ten Principles of the UNGC [

https://www.unglobalcompact.org/what-is-gc/mission/principles] and to make them

part of the strategy, culture and day-to-day operations of our company. This

will help us in strengthening our sustainability agenda and also accelerate our

progress towards achieving our Sustainable Development Goals [

https://www.sailife.com/commitment/sustainability/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

(SDGs)."

    Over the past two years, Sai Life Sciences has made significant investments

and progress in advancing its Sustainability agenda as part of its

organizational transformation initiative, Sai Nxt. Some of the notable

highlights:

    - Became the first India-headquartered company to join the PSCI membership

[

https://gesweb.prnewswire.com//USES/WebForms/TemporaryFolder/3270078-2-1%20(ID-1e7c447e50d4)_Proof.html].

    - Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR

[

https://www.sailife.com/sai-life-sciences-joins-the-acs-green-chemistry-institute-pharmaceutical-roundtable/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory])

as an 'Associate Member'.

    - Released its first Sustainability Report [

https://www.sailife.com/sai-life-sciences-releases-its-first-sustainability-report/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

in 2020 in line with the GRI framework

    - Received the ISO 14001:2015 and ISO 45001:2018 [

https://www.sailife.com/sai-life-sciences-receives-iso-140012015-and-iso-450012018-certification/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

certifications for its R&D and manufacturing sites.

    - Won the prestigious 21st National Award for Excellence in Energy

Management [

https://www.sailife.com/sai-life-sciences-receives-the-21st-national-award-for-excellence-in-energy-management-2020/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

2020 by CII Sohrabji Godrej Green Business Centre

    - Received 5-Star rating for Excellence in EHS Practices [

https://www.sailife.com/sai-life-sciences-manufacturing-facility-achieves-5-star-rating-at-cii-sr-ehs-excellence-awards/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

at the Confederation of Indian Industry (CII) South awards 2019 and 2020.

    About Sai Life Sciences

    Sai Life Sciences is a full-service CRO-CDMO [

https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory]

that works with innovator pharma and biotech companies globally, to accelerate

the discovery, development and commercialisation of complex small molecules.

For over two decades, Sai Life Sciences has consistently delivered

high-quality, cost-effective solutions to its diverse customers spanning

biotechs, small, mid and large pharma. Today, it has over 2200 employees across

its facilities in India, UK and USA. Sai Life Sciences is privately held and

backed by global investors, TPG Capital and HBM Healthcare Investments.

https://www.sailife.com.

    Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg

    Source: Sai Life Sciences